Mastoidectomy Surgery in India
Get Mastoidectomy Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Mastoidectomy Surgery in UAE
Mastoidectomy Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Mastoidectomy is a specialized otological surgical procedure performed to remove diseased mastoid air cells from the temporal bone, typically necessitated by chronic otitis media, cholesteatoma, or mastoiditis that has failed conservative medical management. Modern mastoidectomy achieves disease eradication and hearing preservation in over 90% of appropriately selected cases when performed by high-volume ear surgeons using intraoperative facial nerve monitoring and endoscopic-assisted techniques. GAF Healthcare connects international patients with JCI- and NABH-accredited centers in India and JCI- and DHA-accredited hospitals in the UAE, offering expert surgical care, transparent pricing, and end-to-end medical travel coordination.
Hospital Stay: 2–4 days • Total Stay in Country (Fit-to-Fly): 2–4 weeks • Success Rate: 90–95%
What Is It?
The mastoid bone is a honeycomb-like structure of air cells situated within the petrous portion of the temporal bone, immediately posterior to the external auditory canal. It communicates directly with the middle ear via the aditus ad antrum, making it vulnerable to ascending infection from chronic suppurative otitis media (CSOM). When bacterial or cholesteatomatous disease colonizes these air cells, the resulting osteitis can erode critical adjacent structures—including the tegmen (separating the middle cranial fossa), the sigmoid sinus, the facial nerve canal (Fallopian canal), and the semicircular canals—leading to life-threatening intracranial extension if untreated.
Cholesteatoma, an abnormal accumulation of desquamating keratinized squamous epithelium within the middle ear or mastoid, is the most surgically urgent cause of mastoiditis. Its enzymatic matrix produces collagenases and cytokines (notably IL-1, TNF-α, and matrix metalloproteinases) that actively resorb bone, creating an expanding destructive lesion. Left untreated, cholesteatoma carries a significant risk of labyrinthine fistula, facial nerve palsy, petrous apicitis, meningitis, and sigmoid sinus thrombosis. High-resolution computed tomography (HRCT) of the temporal bones and, increasingly, non-echo-planar diffusion-weighted MRI (DW-MRI) are the cornerstone imaging studies for surgical planning and for distinguishing cholesteatoma from granulation tissue.
The standard of care internationally involves complete surgical removal of all diseased air cells and cholesteatoma matrix while preserving or reconstructing the ossicular chain and tympanic membrane. Contemporary practice at leading centers integrates fully endoscopic or endoscope-assisted microscopic approaches, intraoperative facial nerve monitoring via continuous electromyography (cEMG), and powered instrumentation (microdebriders, diamond burrs). The goal is eradication of disease, creation of a dry, safe ear, and, where possible, optimization of hearing through simultaneous or staged ossiculoplasty and tympanoplasty.
Candidates
• Confirmed chronic suppurative otitis media (CSOM) with unsafe (atticoantral) disease unresponsive to 6–12 weeks of appropriate topical and systemic antibiotic therapy
• Radiologically or surgically confirmed cholesteatoma (acquired or congenital) on HRCT temporal bones; non-EPI DW-MRI used to detect residual or recurrent disease
• Acute coalescent mastoiditis with subperiosteal abscess, Bezold's abscess, or impending intracranial complication
• Coalescent mastoiditis secondary to acute otitis media failing 48–72 hours of intravenous antibiotics
• Mastoid obliteration or revision surgery for recurrent/residual cholesteatoma identified on second-look procedures or surveillance DW-MRI
• Petrous apex cholesteatoma or petrous apicitis (Gradenigo's syndrome) requiring extended mastoidectomy
• Required pre-operative diagnostics: HRCT temporal bones (1 mm axial and coronal slices), non-EPI DW-MRI (for cholesteatoma), pure tone audiogram (PTA) and speech discrimination score (SDS), tympanometry and stapedial reflexes, full blood count, coagulation profile (PT/INR, aPTT), serum electrolytes, renal and hepatic function tests, ECG, anaesthesia fitness assessment
• Relative contraindications: active uncontrolled systemic infection, severe uncorrected coagulopathy, American Society of Anesthesiologists (ASA) Class IV–V status precluding general anaesthesia, the only hearing ear (requires multidisciplinary team decision and detailed counseling)
• Absolute contraindications: patient refusal of surgery after informed consent; medical comorbidities rendering general anaesthesia prohibitively dangerous without optimization
Procedure
Mastoidectomy is not a single procedure but a spectrum of surgical approaches, selected based on disease extent, middle ear anatomy, Eustachian tube function, and surgeon expertise.
**1. Cortical (Simple) Mastoidectomy** The foundational procedure: complete exenteration of all mastoid air cells while preserving the posterior canal wall (PCW) and ossicular chain. Performed via a post-auricular incision using a surgical drill with cutting and diamond burrs under operating microscope magnification (6×–40×). Indicated for acute coalescent mastoiditis and as the drainage component of combined-approach tympanoplasty. Intraoperative facial nerve monitoring (Prass-Luders cEMG) is standard at high-quality centers.
**2. Modified Radical Mastoidectomy (MRM) / Canal Wall Down (CWD) Mastoidectomy** The posterior canal wall is taken down to exteriorize the mastoid cavity, creating a common meatus. Provides the widest surgical exposure and lowest recurrence rate for cholesteatoma. The trade-off is a mastoid bowl requiring lifelong annual micro-suction and water precautions. Meatoplasty is performed to ensure adequate drainage. Indicated for extensive cholesteatoma, sclerotic mastoid, previous failed canal-wall-up surgery, or poor Eustachian tube function.
**3. Canal Wall Up (CWU) / Combined Approach Tympanoplasty (CAT)** Preserves the posterior canal wall, offering a near-normal ear canal and better hearing rehabilitation potential. A planned second-look procedure at 9–18 months is often scheduled to detect residual disease. Increasingly, high-resolution DW-MRI at 18–24 months post-operatively is used to assess for residual cholesteatoma non-invasively, potentially avoiding second-look surgery in selected patients.
**4. Endoscopic Ear Surgery (EES) — Transcanal Endoscopic Mastoidectomy** A transformative advance adopted at elite centers globally. Using 3 mm, 0° and 45° rigid endoscopes (Karl Storz, Storz Hopkins II series; or Olympus EndoEAR system), surgeons achieve superior visualization of hidden recesses—the anterior epitympanum, sinus tympani, and facial recess—that are notoriously blind spots under the microscope. Transcanal endoscopic approaches for limited attic cholesteatoma avoid post-auricular incisions entirely, reduce surgical trauma, and facilitate faster recovery. Endoscope-assisted microscopic surgery (hybrid technique) combines the panoramic view of the endoscope with the bimanual dissection capability of the microscope.
**5. Obliterative / Reconstructive Mastoidectomy** For canal-wall-down cavities, mastoid obliteration using autologous bone pate, bone chips, cartilage, or biocompatible alloplastic materials (hydroxyapatite granules, BioIntegrate) eliminates the problematic mastoid bowl, reducing maintenance requirements and improving quality of life.
**6. Ossiculoplasty and Tympanoplasty** Simultaneous or staged reconstruction of the ossicular chain using autologous incus/cortical bone sculpted prostheses or titanium partial ossicular replacement prostheses (PORP) or total ossicular replacement prostheses (TORP; e.g., Kurz, Heinz Kurz GmbH). Tympanic membrane reconstruction employs temporalis fascia, tragal perichondrium, or cartilage-perichondrium composite grafts. Hearing gain is measured by air-bone gap (ABG) closure; a post-operative ABG ≤20 dB is the benchmark for surgical success.
**7. Technology Integration at Premium Centers** Intraoperative CT (O-arm or Xoran xCAT) for real-time surgical navigation; cochlear implant evaluation for patients with co-existing sensorineural hearing loss; 3D-printed temporal bone models for pre-surgical simulation; and robotic-assisted otological platforms (currently in clinical trials at select centers) represent the frontier of mastoid surgery.
Cost of Mastoidectomy Surgery: India vs. UAE
The cost of mastoidectomy surgery varies significantly depending on the complexity of disease (simple vs. cholesteatoma, primary vs. revision surgery), the surgical approach chosen (endoscopic vs. microscopic, CWU vs. CWD), the need for simultaneous ossiculoplasty or tympanoplasty, and the destination country. India offers world-class otological surgery at costs that are 50–65% lower than comparable procedures in the UAE, making it the preferred destination for cost-conscious international patients. The UAE, particularly Dubai and Abu Dhabi, offers premium hospital environments, luxury recovery facilities, and exceptional logistical convenience for patients traveling from the Gulf Cooperation Council (GCC) region, Africa, and Europe.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $1,500 – $4,500 | ~57% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $4,000 – $10,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
**Pre-Operative Phase (2–4 Weeks Before Surgery)**
• Remote consultation with GAF Healthcare's partner ENT/otologist: review of HRCT temporal bones, DW-MRI, and audiogram uploaded via secure portal
• Pre-operative optimization: treatment of any active infection with culture-directed topical antibiotics (ciprofloxacin/dexamethasone drops) and oral antibiotics; correction of anemia or coagulopathy
• Anaesthesia fitness assessment (ECG, blood work, chest X-ray if indicated)
• Counseling on surgical plan (CWU vs. CWD), hearing expectations, and second-look surgery probability
• Arrival in India or UAE 1–2 days before surgery; hospital admission and final pre-operative assessment
**Day 0 — Surgical Day**
• General anaesthesia (TIVA — total intravenous anaesthesia with propofol/remifentanil, or balanced volatile technique) with laryngeal mask airway or endotracheal intubation depending on duration
• Patient positioned supine with head turned; post-auricular or endaural incision marked
• Intraoperative continuous facial nerve monitoring activated (baseline EMG thresholds established)
• Mastoid cortex exposed; systematic drilling from superficial to deep using Midas Rex or equivalent high-speed drill system
• Disease removal under microscopic and/or endoscopic visualization; ossicular chain assessed
• Tympanoplasty and/or ossiculoplasty performed as indicated; cavity obliterated or meatoplasty created
• Wound closed in layers; mastoid dressing applied
• Procedure duration: 1.5–4 hours depending on complexity
**Post-Operative: Days 1–2 (In-Hospital)**
• Monitoring for facial nerve function (House-Brackmann grading at awakening and every 4 hours)
• IV antibiotics (typically a cephalosporin ± metronidazole for 24–48 hours), then oral step-down
• Analgesia: multimodal regimen (paracetamol, NSAIDs, short-course opioid PRN)
• Vertigo and tinnitus are common transient post-operative symptoms; vestibular sedatives (prochlorperazine, betahistine) as needed
• Mastoid dressing removed at 24–48 hours; drain removed if placed
**Days 3–14 (Outpatient / Hotel Recovery)**
• First outpatient review at Day 7: wound inspection, suture removal, ear canal packing assessment
• Strict water precautions: cotton wool with Vaseline in ear canal; no swimming or submersion
• Avoid nose-blowing; modified Valsalva maneuver precautions
• No air travel, strenuous activity, or heavy lifting for minimum 2–3 weeks
• Antibiotic ear drops commenced once ear canal packing partially removed
**Weeks 3–4 (Fit-to-Fly Assessment)**
• Second outpatient review: complete wound healing confirmed, graft integrity assessed with otoscopy
• Audiogram performed to assess early hearing outcomes
• Physician clearance for international air travel (minimum 2–3 weeks post-op for uncomplicated cases; 3–4 weeks for complex or bilateral cases)
• Comprehensive discharge summary, imaging CDs, histopathology report (if cholesteatoma), and follow-up plan issued
**Months 1–18 (Home Follow-Up)**
• Audiogram at 3 months and 6 months post-operatively
• Non-EPI DW-MRI at 12–18 months to screen for residual cholesteatoma (CWU cases)
• Annual micro-suction for canal-wall-down cavities
• Hearing aid assessment or ossiculoplasty planning if residual conductive hearing loss persists (ABG >20 dB)
Risks & Considerations
Mastoidectomy is a safe procedure in experienced hands, but patients must be counseled on procedure-specific risks with transparency. Facial nerve injury is the most feared complication: the facial nerve traverses the mastoid in its vertical (mastoid) segment, and inadvertent drill or instrument injury can cause temporary or permanent paresis. At high-volume centers with continuous intraoperative facial nerve monitoring, the risk of permanent facial paralysis is less than 1%; transient neuropraxia occurs in 1–4% of cases. Sensorineural hearing loss (SNHL) can result from drill vibration transmitted to the cochlea, perilymph fistula, or inadvertent labyrinthine fistula during cholesteatoma removal from the semicircular canals; the risk is 1–3% for high-frequency SNHL in experienced hands. Tinnitus and post-operative vertigo are common transient phenomena (15–30%) and typically resolve within weeks; persistent dizziness requiring vestibular rehabilitation occurs in approximately 5% of cases. Graft failure (tympanic membrane perforation or lateralization) occurs in 5–10% of tympanoplasties and may require revision surgery. Cholesteatoma recurrence or residual disease is the primary long-term concern in canal-wall-up procedures, with reported rates of 10–30% over 5 years, underscoring the importance of DW-MRI surveillance or planned second-look surgery. Rare but serious complications include meningitis (<0.5%), sigmoid sinus thrombophlebitis, CSF leak from inadvertent dural injury (<1%), and wound infection. Patients with extensive or revision disease should have detailed pre-operative counseling using validated consent tools and, ideally, a documented discussion of House-Brackmann grading and audiological risk.
Top Hospitals for Mastoidectomy Surgery
Top Doctors for Mastoidectomy Surgery
Internationally trained specialists in ENT. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. T. S. Kler
MBBS, MD (Medicine), DM (Cardiology), MRCP (UK), FRCP (UK), FACC (USA), D.Sc (Honoris Causa)
Interventional Cardiologist & Electrophysiologist
BLK-Max Super Speciality Hospital, New Delhi, India
37+ Yearsof experience
Dr. T. S. Kler is the Chairman and Head of Department at BLK-Max Heart & Vascular Institute and Chairman of Pan Max Electrophysiology, serving as a leading interventional cardiologist and electrophysiologist. With over 37 years of clinical excellence, he holds distinguished international credentials including FRCP (UK), FACC (USA), and an honorary D.Sc. from Punjab University, recognising his pioneering contributions to cardiology. Dr. Kler's clinical… Read more
Dr. Gopi Srikanth
MBBS, MD Internal Medicine, DM Gastroenterology and Hepatology, Fellowship in Pancreatology, Fellowship in Endoscopic Ultrasound
Gastroenterologist
Yashoda Hospitals, Hyderabad, India
10+ Yearsof experience
Dr. Gopi Srikanth is a Consultant Gastroenterologist and Hepatobiliary specialist at Yashoda Hospitals in Hyderabad, bringing over 10 years of clinical expertise in digestive and liver disease management. He holds a DM in Gastroenterology and Hepatology from AIIMS New Delhi and completed advanced fellowships in Pancreatology and Endoscopic Ultrasound from prestigious institutions including the World Endoscopy Organisation, which distinguish him as a… Read more
Dr. Guruprasad Shetty
MBBS, MS (General Surgery), DNB (General Surgery), FMAS, FIAGES, Fellowship in Surgical Gastroenterology and Minimally Invasive Surgery
Surgical Gastroenterologist & Hepatobiliary Surgeon
Apollo Hospitals, Mumbai, India
15+ Yearsof experience
Dr. Guruprasad Shetty is a Senior Consultant in Surgical Gastroenterology, Hepatopancreaticobiliary, and Transplant Surgery at Apollo Hospitals in Mumbai, bringing over 15 years of specialized surgical expertise. He holds exceptional credentials including MBBS, MS in General Surgery, DNB, FMAS (Fellowship in Minimal Access Surgery), and FIAGES, alongside a specialized fellowship in Surgical Gastroenterology and Minimally Invasive Surgery. His… Read more
Dr. Hitesh Panchal
MBBS, MD in Internal Medicine, DrNB in Gastroenterology
Gastroenterologist
Medanta - The Medicity, Gurgaon, India
9+ Yearsof experience
Dr. Hitesh Panchal is an Associate Consultant in Gastroenterology & Hepatobiliary Medicine at Medanta – The Medicity in Gurgaon, bringing 9+ years of clinical experience to the care of complex digestive and liver disorders. He completed his medical training at the esteemed B.J. Medical College, Ahmedabad, earning his MBBS in 2017 and MD in Internal Medicine in 2020, before pursuing his DrNB in Gastroenterology at Medanta, one of India's leading… Read more
Dr. Jatin Yegurla
MBBS, MD, DM
Gastroenterologist and Hepatologist
Apollo Hospital, Jubilee Hills, Hyderabad, India
10+ Yearsof experience
Dr. Jatin Yegurla is a Consultant Gastroenterologist and Hepatologist based at Apollo Hospital, Jubilee Hills in Hyderabad, with over 10 years of clinical expertise. He holds an MBBS degree, MD in Internal Medicine from PGIMER Chandigarh, and a DM in Gastroenterology, establishing a strong academic foundation in digestive health and hepatology. His comprehensive qualifications and sustained commitment to the specialty reflect his dedication to… Read more
Frequently Asked Questions — Mastoidectomy Surgery
The cost of mastoidectomy surgery in India typically ranges from USD 1,500 to USD 4,500, depending on the complexity of the procedure (e.g., simple cortical mastoidectomy vs. canal-wall-down surgery with ossiculoplasty and tympanoplasty for cholesteatoma), surgeon seniority, and hospital tier (NABH- or JCI-accredited institutions). In the UAE (Dubai or Abu Dhabi), the equivalent procedure costs approximately USD 4,000 to USD 10,000, reflecting higher hospital overhead, facility luxury standards, and the premium associated with DHA- and JCI-accredited private hospitals. India is generally 50–65% more affordable for equivalent surgical quality and is the preferred destination for patients from Asia, Africa, and Europe seeking cost-effective, high-expertise otological care. The UAE is advantageous for GCC residents and patients prioritizing proximity, luxury recovery environments, and minimal travel time. Both destinations include surgery, general anaesthesia, 2–4 days of inpatient care, standard medications, and basic post-operative follow-up in the quoted range. Ossiculoplasty with titanium PORP/TORP prostheses, intraoperative CT navigation, or extended petrous apex surgery may add to the cost. GAF Healthcare provides itemized, transparent cost estimates before any commitment is made.
Most patients undergoing primary mastoidectomy surgery (without major complications) require a minimum stay of 2–3 weeks in the treating country before they are medically cleared for international air travel. The typical hospital admission is 2–4 days, after which patients transition to outpatient recovery in a nearby hotel or serviced apartment. The key clinical milestones before air travel clearance include: complete surgical wound healing (assessed at the Day 7 suture-removal visit), absence of active infection or wound dehiscence, stable tympanic membrane graft integrity, resolution of significant post-operative vertigo (which carries a falls and disorientation risk during travel), and no concern for middle ear barotrauma. Cabin pressure changes during flight create fluctuating middle ear pressure, which can stress a fresh tympanic membrane graft or precipitate perilymph fistula in the early post-operative period. For complex revision cases, bilateral procedures, or patients who experienced intraoperative complications, the fit-to-fly period is extended to 3–4 weeks. Your GAF Healthcare coordinator will arrange a formal fit-to-fly assessment with your treating otologist before your departure date is confirmed, and a detailed medical clearance letter will be provided for airline and travel insurance purposes.
Mastoidectomy surgery performed by high-volume, fellowship-trained otologists at accredited centers achieves disease eradication rates of 90–95% for primary cases. When the endpoint is defined as a dry, safe, and infection-free ear at 12 months post-operatively, success rates across published international series range from 88% to 96%. For cholesteatoma specifically, the choice of surgical technique influences recurrence risk: canal-wall-down (modified radical mastoidectomy) procedures have a lower cholesteatoma recurrence rate of approximately 5–10% over 5 years compared to canal-wall-up approaches, which carry a residual/recurrent disease rate of 10–30% (necessitating surveillance DW-MRI or planned second-look surgery). Hearing improvement outcomes are measured by air-bone gap (ABG) closure; approximately 70–80% of patients undergoing simultaneous ossiculoplasty achieve a post-operative ABG of 20 dB or less, representing a functionally significant hearing gain. The risk of permanent facial nerve palsy is less than 1% at centers using continuous intraoperative electromyographic facial nerve monitoring. GAF Healthcare partners exclusively with centers where treating surgeons have documented case volumes and audit their outcomes against international benchmarks set by the European Academy of Otology and Neurotology (EAONO) and the American Otological Society (AOS).
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides comprehensive, concierge-level non-medical coordination for every international patient undergoing mastoidectomy surgery in India or the UAE.
**India — e-Medical Visa Assistance:** GAF Healthcare's documentation team guides patients through the Indian e-Medical Visa application (available to citizens of over 170 countries), including preparation of the invitation letter from the treating hospital, submission of medical records, and photo/passport specifications. Visas are typically approved within 72 hours. Medical attendant visas (e-Medical-X) are simultaneously processed for up to two family members accompanying the patient.
**UAE (Dubai / Abu Dhabi) — Entry Facilitation:** Citizens of most GCC, EU, UK, US, and Commonwealth countries receive visa-free or visa-on-arrival access to the UAE. For nationalities requiring advance visas, GAF Healthcare coordinates hospital-sponsored medical visit visas through partner facilities licensed by the Dubai Health Authority (DHA) or Department of Health Abu Dhabi (DoH). Insurance pre-authorization documentation is prepared on request.
**Airport Transfers:** Private, air-conditioned vehicle transfers are arranged for all arrival and departure journeys, with GAF Healthcare's ground team meeting patients at the airport. Wheelchair assistance and porter services are pre-requested for patients with mobility limitations.
**Dedicated Medical Coordinators and Translators:** Each patient is assigned a personal GAF Healthcare coordinator fluent in the patient's language (Arabic, Russian, French, Swahili, Bengali, and others available) who accompanies them to all hospital appointments, surgical consultations, and discharge meetings. This coordinator bridges communication between the surgical team and the patient's family throughout the hospital stay.
**Attendant Accommodation:** GAF Healthcare pre-negotiates discounted rates at partner hotels and serviced apartments within 1–3 km of treating hospitals in Mumbai, Delhi, Chennai, Hyderabad, Bangalore, Dubai, and Abu Dhabi. Options range from standard hotel rooms to fully serviced apartments with kitchenettes for longer stays, catering to the patient's attendant or family members.
**Post-Discharge Support:** Digital copies of all medical records, histopathology reports, imaging CDs, and discharge summaries are organized and couriered or uploaded to the patient's GAF portal. Telemedicine follow-up appointments with the treating surgeon are scheduled prior to departure to ensure continuity of care upon return home.